Literature DB >> 36071109

Tractography-based versus anatomical landmark-based targeting in vALIC deep brain stimulation for refractory obsessive-compulsive disorder.

Ilse Graat1, Roel J T Mocking2, Luka C Liebrand2,3, Pepijn van den Munckhof4, Maarten Bot4, P Rick Schuurman4, Isidoor O Bergfeld2,5, Guido van Wingen2,5, Damiaan Denys2.   

Abstract

Deep brain stimulation (DBS) of the ventral anterior limb of the internal capsule (vALIC) is effective for refractory obsessive-compulsive disorder (OCD). Retrospective evaluation showed that stimulation closer to the supero-lateral branch of the medial forebrain bundle (slMFB), within the vALIC, was associated with better response to DBS. The present study is the first to compare outcomes of DBS targeted at the vALIC using anatomical landmarks and DBS with connectomic tractography-based targeting of the slMFB. We included 20 OCD-patients with anatomical landmark-based DBS of the vALIC that were propensity score matched to 20 patients with tractography-based targeting of electrodes in the slMFB. After one year, we compared severity of OCD, anxiety and depression symptoms, response rates, time to response, number of parameter adjustments, average current, medication usage and stimulation-related adverse effects. There was no difference in Y-BOCS decrease between patients with anatomical landmark-based and tractography-based DBS. Nine (45%) patients with anatomical landmark-based DBS and 13 (65%) patients with tractography-based DBS were responders (BF10 = 1.24). The course of depression and anxiety symptoms, time to response, number of stimulation adjustments or medication usage did not differ between groups. Patients with tractography-based DBS experienced fewer stimulation-related adverse effects than patients with anatomical landmark-based DBS (38 vs 58 transient and 1 vs. 17 lasting adverse effects; BF10 = 14.968). OCD symptoms in patients with anatomical landmark-based DBS of the vALIC and tractography-based DBS of the slMFB decrease equally, but patients with tractography-based DBS experience less adverse effects.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 36071109     DOI: 10.1038/s41380-022-01760-y

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  23 in total

1.  Invasive and Non-invasive Neurostimulation for OCD.

Authors:  Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Individual white matter bundle trajectories are associated with deep brain stimulation response in obsessive-compulsive disorder.

Authors:  L C Liebrand; M W A Caan; P R Schuurman; P van den Munckhof; M Figee; D Denys; G A van Wingen
Journal:  Brain Stimul       Date:  2018-11-27       Impact factor: 8.955

Review 3.  Connectomic Deep Brain Stimulation for Obsessive-Compulsive Disorder.

Authors:  Juan Carlos Baldermann; Thomas Schüller; Sina Kohl; Valerie Voon; Ningfei Li; Barbara Hollunder; Martijn Figee; Suzanne N Haber; Sameer A Sheth; Philip E Mosley; Daniel Huys; Kara A Johnson; Christopher Butson; Linda Ackermans; Tim Bouwens van der Vlis; Albert F G Leentjens; Michael Barbe; Veerle Visser-Vandewalle; Jens Kuhn; Andreas Horn
Journal:  Biol Psychiatry       Date:  2021-07-19       Impact factor: 13.382

4.  The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder.

Authors:  Volker A Coenen; Thomas E Schlaepfer; Peter Goll; Peter C Reinacher; Ulrich Voderholzer; Ludger Tebartz van Elst; Horst Urbach; Tobias Freyer
Journal:  CNS Spectr       Date:  2016-06-08       Impact factor: 3.790

5.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

6.  Efficacy of Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Refractory Obsessive-Compulsive Disorder: A Clinical Cohort of 70 Patients.

Authors:  Damiaan Denys; Ilse Graat; Roel Mocking; Pelle de Koning; Nienke Vulink; Martijn Figee; Pieter Ooms; Mariska Mantione; Pepijn van den Munckhof; Rick Schuurman
Journal:  Am J Psychiatry       Date:  2020-01-07       Impact factor: 18.112

7.  A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder.

Authors:  Ningfei Li; Juan Carlos Baldermann; Astrid Kibleur; Svenja Treu; Harith Akram; Gavin J B Elias; Alexandre Boutet; Andres M Lozano; Bassam Al-Fatly; Bryan Strange; Juan A Barcia; Ludvic Zrinzo; Eileen Joyce; Stephan Chabardes; Veerle Visser-Vandewalle; Mircea Polosan; Jens Kuhn; Andrea A Kühn; Andreas Horn
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

8.  Machine learning-aided personalized DTI tractographic planning for deep brain stimulation of the superolateral medial forebrain bundle using HAMLET.

Authors:  Volker A Coenen; Thomas E Schlaepfer; Peter C Reinacher; Hansjoerg Mast; Horst Urbach; Marco Reisert
Journal:  Acta Neurochir (Wien)       Date:  2019-05-30       Impact factor: 2.216

9.  The challenge of mapping the human connectome based on diffusion tractography.

Authors:  Klaus H Maier-Hein; Peter F Neher; Jean-Christophe Houde; Marc-Alexandre Côté; Eleftherios Garyfallidis; Jidan Zhong; Maxime Chamberland; Fang-Cheng Yeh; Ying-Chia Lin; Qing Ji; Wilburn E Reddick; John O Glass; David Qixiang Chen; Yuanjing Feng; Chengfeng Gao; Ye Wu; Jieyan Ma; Renjie He; Qiang Li; Carl-Fredrik Westin; Samuel Deslauriers-Gauthier; J Omar Ocegueda González; Michael Paquette; Samuel St-Jean; Gabriel Girard; François Rheault; Jasmeen Sidhu; Chantal M W Tax; Fenghua Guo; Hamed Y Mesri; Szabolcs Dávid; Martijn Froeling; Anneriet M Heemskerk; Alexander Leemans; Arnaud Boré; Basile Pinsard; Christophe Bedetti; Matthieu Desrosiers; Simona Brambati; Julien Doyon; Alessia Sarica; Roberta Vasta; Antonio Cerasa; Aldo Quattrone; Jason Yeatman; Ali R Khan; Wes Hodges; Simon Alexander; David Romascano; Muhamed Barakovic; Anna Auría; Oscar Esteban; Alia Lemkaddem; Jean-Philippe Thiran; H Ertan Cetingul; Benjamin L Odry; Boris Mailhe; Mariappan S Nadar; Fabrizio Pizzagalli; Gautam Prasad; Julio E Villalon-Reina; Justin Galvis; Paul M Thompson; Francisco De Santiago Requejo; Pedro Luque Laguna; Luis Miguel Lacerda; Rachel Barrett; Flavio Dell'Acqua; Marco Catani; Laurent Petit; Emmanuel Caruyer; Alessandro Daducci; Tim B Dyrby; Tim Holland-Letz; Claus C Hilgetag; Bram Stieltjes; Maxime Descoteaux
Journal:  Nat Commun       Date:  2017-11-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.